Linked Life Data

20132203

Source:http://linkedlifedata.com/resource/pubmed/id/20132203

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20132203rdf:typepubmed:Citationlld:pubmed
pubmed-article:20132203lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C0878773lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C0388753lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C0069805lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C2343853lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C0010181lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C0027462lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C0138666lld:lifeskim
pubmed-article:20132203lifeskim:mentionsumls-concept:C1099677lld:lifeskim
pubmed-article:20132203pubmed:issue4lld:pubmed
pubmed-article:20132203pubmed:dateCreated2010-7-26lld:pubmed
pubmed-article:20132203pubmed:abstractTextTo assess the cost-effectiveness of solifenacin vs other antimuscarinic strategies commonly used in UK clinical practice, based on the results of a recent published review.lld:pubmed
pubmed-article:20132203pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:languageenglld:pubmed
pubmed-article:20132203pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:citationSubsetIMlld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20132203pubmed:statusMEDLINElld:pubmed
pubmed-article:20132203pubmed:monthAuglld:pubmed
pubmed-article:20132203pubmed:issn1464-410Xlld:pubmed
pubmed-article:20132203pubmed:authorpubmed-author:CardozoLindaLlld:pubmed
pubmed-article:20132203pubmed:authorpubmed-author:WarnerJulietJlld:pubmed
pubmed-article:20132203pubmed:authorpubmed-author:ThorpeAndrewAlld:pubmed
pubmed-article:20132203pubmed:authorpubmed-author:SidhuManpreet...lld:pubmed
pubmed-article:20132203pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20132203pubmed:volume106lld:pubmed
pubmed-article:20132203pubmed:ownerNLMlld:pubmed
pubmed-article:20132203pubmed:authorsCompleteYlld:pubmed
pubmed-article:20132203pubmed:pagination506-14lld:pubmed
pubmed-article:20132203pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:meshHeadingpubmed-meshheading:20132203...lld:pubmed
pubmed-article:20132203pubmed:year2010lld:pubmed
pubmed-article:20132203pubmed:articleTitleThe cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.lld:pubmed
pubmed-article:20132203pubmed:affiliationUrogynaecology, Kings' College Hospital, London, UK.lld:pubmed
pubmed-article:20132203pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20132203pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20132203pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20132203lld:pubmed